You're reading the free version. Trader adds the live tape and alerts.
Start tracking
AGIO Exercise Disclosure
Scadden David · SEC Form 4 · Filed Jun 23, 2026
Exercise
Calculated transaction value
$0
Scadden David Director
AGIO
Transaction date
Jun 18, 2026
Public filing date
Jun 23, 2026
Filing lag
Filed 5 days later
AGIO daily price context
Close on/before transaction
$34.16
Jun 18, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Restricted stock units on Common stock
- Quantity / price
- 2,816 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001439222-26-000095
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Agios Pharmaceuticals, Inc. AGIO | Exercise | Jun 18, 2026 | $0 |
| Agios Pharmaceuticals, Inc. AGIO Current | Exercise | Jun 18, 2026 | $0 |
| Agios Pharmaceuticals, Inc. AGIO | Award | Jun 18, 2026 | $0 |
| Agios Pharmaceuticals, Inc. AGIO | Award | Jun 18, 2026 | $0 |